Farringdon Capital Ltd. Invests $250,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Farringdon Capital Ltd. acquired a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 3,198 shares of the company’s stock, valued at approximately $250,000.

A number of other large investors have also recently bought and sold shares of the business. Kestra Investment Management LLC bought a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth about $27,000. CIBC Private Wealth Group LLC grew its holdings in Prestige Consumer Healthcare by 48.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock valued at $34,000 after purchasing an additional 152 shares during the last quarter. Headlands Technologies LLC bought a new position in shares of Prestige Consumer Healthcare in the fourth quarter valued at approximately $40,000. GAMMA Investing LLC lifted its stake in shares of Prestige Consumer Healthcare by 18.9% in the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after buying an additional 220 shares during the last quarter. Finally, Huntington National Bank boosted its holdings in shares of Prestige Consumer Healthcare by 133.2% during the 4th quarter. Huntington National Bank now owns 1,481 shares of the company’s stock worth $116,000 after buying an additional 846 shares during the period. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Stock Up 0.4 %

NYSE PBH opened at $80.10 on Friday. Prestige Consumer Healthcare Inc. has a 1-year low of $62.35 and a 1-year high of $90.04. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The stock’s 50 day moving average is $84.16 and its two-hundred day moving average is $80.16. The company has a market capitalization of $3.97 billion, a price-to-earnings ratio of 18.76, a PEG ratio of 2.69 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Analysts Set New Price Targets

PBH has been the topic of several research analyst reports. DA Davidson raised their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Oppenheimer upped their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday, February 13th. Royal Bank of Canada raised their price objective on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a “sector perform” rating in a research note on Friday, March 21st. Canaccord Genuity Group increased their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a report on Friday, February 7th. Finally, StockNews.com downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, April 8th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $93.33.

Insiders Place Their Bets

In related news, SVP Mary Beth Fritz sold 1,678 shares of the firm’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at $1,544,130. This trade represents a 8.91 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.60% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.